Vantage Point: new era of marketing research

Share this article:
For years, healthcare marketing research has begun with a proposal and ended with a final report containing “conclusions” and “recommendations.” A group other than the marketing research team, often an agency, would then implement the recommendations, frequently by selection or modification of various promotional pieces such as detail aids and advertisements.

But we are entering a new era. We are at the precipice of the generic cliff, the world is moving toward personalized medicine, and e-prescribing and patient records are coming to fruition. All of this in the face of a relatively minimalistic healthcare reform bill stalled in Congress and a healthcare system costing one-sixth of the GDP that is still going broke.

What does this mean for marketing research? The trend toward decreasing spend on promotional research will continue. Look for teams of marketing researchers and designers to produce usable healthcare tools, not conclusions and recommendations, and not changes in advertising copy.

These information-based tools, using digital media such as touch-screen computers and PDAs, will help healthcare become more effective and efficient. We will work on such issues as patient-compliance programs, assisting physicians in digesting the voluminous information required by personalized medicine, helping nonphysician caregivers shoulder more of the workload, and motivating patients in their pursuit of wellness rather than dealing with illness.

To pursue these goals, we will develop and use new methodologies for determining information-consumption patterns and information needs. And we will communicate with our colleagues to turn our findings into useful tools, not just recommendations. 

Richard Vanderveer is CEO of GfK Healthcare
Share this article:
close

Next Article in Vantage Point

Email Newsletters

More in Vantage Point

Vantage Point: Observational Research

Vantage Point: Observational Research

Pharma can be in the moment with customers as they interact with our information or products

Vantage Point: Big Data

Vantage Point: Big Data

Big Data is coming and with it the danger of pharmaceutical marketers relying on it too heavily

Vantage Point: Ringing in the new market

Vantage Point: Ringing in the new market

In 2014, the "new healthcare marketing" will become more discontinuous from the old